Co-Authors
                            
                            
                                This is a "connection" page, showing publications co-authored by   JONATHAN LEI   and   MOTHAFFAR RIMAWI.
                            
                            
                            
                                
                                    
                                            
    
        
        
        
            Connection Strength
            
                
            
            0.392
         
        
        
     
 
    
        
        - 
            Patient-Derived Xenografts of Triple-Negative Breast Cancer Enable Deconvolution and Prediction of Chemotherapy Responses. bioRxiv. 2025 Jan 08.
            
            
                Score: 0.236
             
- 
            Kinase Inhibitor Pulldown Assay Identifies a Chemotherapy Response Signature in Triple-negative Breast Cancer Based on Purine-binding Proteins. Cancer Res Commun. 2023 08; 3(8):1551-1563.
            
            
                Score: 0.054
             
- 
            Identifying biomarkers of differential chemotherapy response in TNBC patient-derived xenografts with a CTD/WGCNA approach. iScience. 2023 Jan 20; 26(1):105799.
            
            
                Score: 0.051
             
- 
            Proteogenomic Markers of Chemotherapy Resistance and Response in Triple-Negative Breast Cancer. Cancer Discov. 2022 11 02; 12(11):2586-2605.
            
            
                Score: 0.051